Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial
OBJECTIVE: To evaluate the efficacy and safety of galantamine in the treatment of Alzheimer's disease. DESIGN: Randomised, double blind, parallel group, placebo controlled trial. SETTING: 86 outpatient clinics in Europe and Canada. PARTICIPANTS: 653 patients with mild to moderate Alzheimer's disease...
保存先:
| 出版年: | BMJ |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2000
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC27547/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11110737/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bmj.321.7274.1445 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|